Patents by Inventor Shari PHILON-THOMAS

Shari PHILON-THOMAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of Ex Vivo Enhancement of Immune Cell Activity for Cancer Immunotherapy with a Small Molecule Ablative Compound
    Publication number: 20190030074
    Abstract: A cancer immunotherapy method is disclosed in which “induced immune anticancer agents” are isolated after being induced in an animal host by intralesional (IL) administration of a halogenated xanthene tumor-ablative compound into a solid cancerous tumor of that host animal. A sample of the induced immune anticancer agents is removed (collected) from the tumor-bearing host, banked if desired, cultured and preferentially expanded to form an immunologically-effective enriched tumor-specific immune anticancer agent composition. That composition is reintroduced in to the host from which the predecessor induced immune anticancer agents were taken, or into another immunologically suitable host in need.
    Type: Application
    Filed: October 2, 2018
    Publication date: January 31, 2019
    Applicants: Provectus Pharmatech, Inc., H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: Jamie SINGER, Eric A. WACHTER, Amod SARNAIK, Shari PHILON-THOMAS, Hao LIU